Researchers at the Norwegian University of Science and Technology have found that JAK inhibitors may weaken the body’s defenses. These drugs can increase vulnerability to viral infections, such as COVID-19 and influenza. By suppressing immune responses, these medications facilitate easier spread of viruses within the body. Caution is advised for healthcare professionals when prescribing these drugs during outbreaks.
